NMDA and 5-HT2A receptor dysfunction in working memory deficits in schizophrenia

被引：1
|
作者：
Umbricht, D [1 ]
Vollenweider, FX [1 ]
Schmid, L [1 ]
Koller, R [1 ]
机构：
[1] Psychiat Univ Hosp Zurich, Res Dept, CH-8029 Zurich, Switzerland
来源：
BIOLOGICAL PSYCHIATRY | 2000年 / 47卷 / 08期
关键词：
D O I：
10.1016/S0006-3223(00)00439-X
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
177
引用
收藏
页码：53S / 53S
页数：1
相关论文
共 50 条
  • [41] 5-HT1A receptor sensitivity after 5-HT2A receptor downregulation
    Hensler, JG
    Truett, KA
    BIOLOGICAL PSYCHIATRY, 1996, 39 (07) : 116 - 116
  • [42] G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits
    Kossatz, Elk
    Diez-Alarcia, Rebeca
    Gaitonde, Supriya A.
    Ramon-Duaso, Carla
    Stepniewski, Tomasz Maciej
    Aranda-Garcia, David
    Muneta-Arrate, Itziar
    Tepaz, Elodie
    Saen-Oon, Suwipa
    Soliva, Robert
    Shahraki, Aida
    Moreira, David
    Brea, Jose
    Loza, Maria Isabel
    de la Torre, Rafael
    Kolb, Peter
    Bouvier, Michel
    Meana, J. Javier
    Robledo, Patricia
    Selent, Jana
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [43] Synthesis and 5-HT2A radioligand receptor binding assays of DOMCI and DOMOM, two novel 5-HT2A receptor ligands
    Harms, A
    Ulmer, E
    Kovar, KA
    ARCHIV DER PHARMAZIE, 2003, 336 (03) : 155 - 158
  • [44] 5-HT2A and muscarinic receptors in schizophrenia:: a postmortem study
    Matsumoto, I
    Inoue, Y
    Iwazaki, T
    Pavey, G
    Dean, B
    NEUROSCIENCE LETTERS, 2005, 379 (03) : 164 - 168
  • [45] ACP-103, a 5-HT2A receptor inverse agonist, as an adjunctive therapy in schizophrenia
    Vanover, Kimberly E.
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 101 : 43 - 43
  • [46] 5-HT2A receptor polymorphism and susceptibility to tardive dyskinesia in patients with chronic schizophrenia.
    Segman, RH
    Levy, UH
    Finkel, B
    Greenberg, D
    Yakir, A
    Schlaffman, M
    Dorevich, A
    Goltser, T
    Lerer, B
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 96 (04): : 526 - 526
  • [47] Atypical antipsychotics, schizophrenia and cortical 5-HT2A receptors
    Collier, DA
    MOLECULAR PSYCHIATRY, 1998, 3 (03) : 211 - 211
  • [48] Platelet 5-HT2A receptors and chronic outcome in schizophrenia
    Loza, M. I.
    Dominguez, E.
    Padin, F.
    Alvarez, V.
    Paz, E.
    Brenlla, J.
    Buceta, M.
    Carracedo, A.
    Cadavid, M. I.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 43 - 43
  • [49] Multimodal working memory deficits in schizophrenia
    Bates, J
    Johnson, R
    Ehrlichman, H
    Javitt, D
    Bilder, R
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2002, 17 (08) : 815 - 815
  • [50] Working and strategic memory deficits in schizophrenia
    Stone, M
    Gabrieli, JDE
    Stebbins, GT
    Sullivan, EV
    NEUROPSYCHOLOGY, 1998, 12 (02) : 278 - 288
12345